Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
Advertisement
The Scientist
Most Recent
How plants pass defenses to offspring through a complex molecular network
African justice systems must change to help curb HIV and tuberculosis transmission in prisons.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
With 12 new tuberculosis vaccines in clinical development, a plan is needed to introduce the most effective ones throughout the world.
In rhesus macaques, an individual's drop in the social hierarchy leads to overactive immune genes and, possibly, poor health.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
